Flyer

Health Science Journal

  • ISSN: 1108-7366
  • Journal h-index: 61
  • Journal CiteScore: 17.30
  • Journal Impact Factor: 18.23
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • CINAHL Complete
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • EMCare
  • OCLC- WorldCat
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEO
  • Secret Search Engine Labs
Share This Page

Swapnaja Gulawani

Bioprospecting Group, MACS-Agharkar Research Institute, India

Publications
  • Review Article   
    Reactive Oxygen Species in Cancer Management: Understanding the Transformation of Antagonists Turning Allies
    Author(s): Swapnaja Gulawani, ., Swaroop Kumar Pandey and Pratibha Srivastava*

    Cancer is uncontrolled mitosis where reactive oxygen species (ROS) act as one of the mito- gens. Although elevated ROS concentrations are one of the key points in the development and spread of cancer, exceeding the threshold limit becomes lethal to cancer cells. Due to an independent anti-oxidant system and metabolic reprogramming, cancer cells can withstand high ROS concentrations (e.g., the Warburg effect). The ability of cancer cells to control ROS levels is an intricate strength and a crucial factor for effective cancer treatment. Multiple cancer therapies, like radiotherapy and chemotherapy, rely on ROS accretion to induce cancer cell death but they simultaneously they damage normal cells. These therapies intended to block this adaptation should be expected to kill cancer cells. Alteration in the nature of cancer cells by ROS-generating molecules and making them more selective fo.. View More»

    Abstract HTML PDF